C4 Therapeutics Inc.
CCCC | NASDAQ
$3.31
+$0.01 (+0.30%)
Sep 22, 2026, 1:39 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -23.64M | -25.13M | -20.49M | -32.17M | -26.02M | -26.32M | -34.57M | -24.67M | -17.72M | -28.36M | -34.75M | -27.04M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M | -20.97M |
Depreciation & Amortization | 3.19M | 404K | 428K | 460K | 615K | 456K | 480K | 442K | 448K | 448K | 1.69M | 447K | 458K | 545K | 521K | 415K | 435K | 305K | 323K | 330K | 388K | 451K |
Stock-Based Compensation | 3.04M | 2.67M | 4.01M | 4.59M | 4.99M | 5.51M | 8.24M | 8.83M | 6.38M | 6.22M | 6.36M | 8.2M | 6.43M | 6.25M | 6.92M | 6.01M | 8.15M | 8.94M | 6.35M | 6.09M | 5.23M | 3.85M |
Other Working Capital | 15.56M | -7.71M | -10.35M | -10.8M | -114K | -8.25M | 360K | -416K | -5.85M | 4.97M | 14.53M | -10.57M | 8.8M | -7.03M | 401K | -2.74M | -6.32M | -9.04M | -18.04M | -1.93M | 15K | -7.73M |
Other Non-Cash Items | -1.62M | 382K | 587K | 11.94M | 1.11M | 892K | 503K | 260K | 45K | 223K | 20.16M | 1.65M | 667K | 1.08M | 1.28M | 1.72M | 2.3M | 2.02M | 1.46M | 1.07M | 877K | 604K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.87M | -472K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 17.45M | -8.27M | -6.68M | -16.03M | 7.25M | -13.82M | 7.42M | -9M | 5.87M | 3.36M | 3.4M | -13.5M | 9.38M | -6.22M | -660K | -4.21M | -5.67M | -6.24M | -18.15M | -1.16M | -1.92M | -8.86M |
Operating Cash Flow | -1.57M | -29.94M | -22.15M | -31.21M | -12.06M | -33.29M | -17.93M | -24.13M | -4.97M | -18.12M | -24.01M | -30.71M | -19M | -33.13M | -29.13M | -28.02M | -22.2M | -26.6M | -25.67M | -18.36M | -18M | -24.93M |
Capital Expenditures | -37K | -64K | -11K | -411K | -185K | n/a | 4K | 13K | -197K | n/a | -157K | -600K | -362K | -589K | -1.49M | -3.31M | -529K | -172K | -109K | n/a | -747K | -421K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.1M | -58.33M | n/a | -54.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -70.83M | -40.81M | -133.07M | -46.68M | -21.68M | -25.64M | -40.78M | -68.57M | -67.22M | -107.75M | -37.88M | -31.94M | -48.64M | -11.44M | -56.29M | -55.11M | -31.91M | -76.22M | -145.42M | -154.7M | -61.32M | -176.3M |
Sales Maturities Of Investments | 56.05M | 57.03M | 52.35M | 51.18M | 60.79M | 54.77M | 54.45M | 68.71M | 55.72M | 54.35M | 69.98M | 90.27M | 64.15M | 65.56M | 67.06M | 78.33M | 65.67M | 72.39M | 86.11M | 54.08M | 94.5M | 114.99M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 32.1M | 58.33M | n/a | 54.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -14.82M | 16.15M | -80.73M | 4.09M | 38.92M | 29.13M | 13.67M | 162K | -11.71M | -53.4M | 31.95M | 57.73M | 15.15M | 53.53M | 9.28M | 19.91M | 33.23M | -4M | -59.41M | -100.63M | 32.43M | -61.73M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11M | -750K | -750K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -200K | -14K | -24K | n/a | -155K | n/a | -85K | n/a | -109K | n/a | -16K | n/a | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1K | 56K | 1K | 271K | n/a | 109K | 1K | 310K | n/a | 603K | -1K | 263K | 4K | 104K | n/a | 150K | n/a | 220K | -286K | 1.05M | n/a | -3K |
Financial Cash Flow | 33.73M | 462K | 118.67M | 7.77M | n/a | -46K | 112K | 10.51M | 135K | 34.58M | 57.67M | -10.75M | -746K | -684K | 47K | 361K | 259K | 480K | 466K | 584K | 170.5M | -151K |
Net Cash Flow | 17.34M | -13.33M | 15.79M | -19.35M | 26.86M | -4.21M | -4.15M | -13.47M | -16.55M | -36.93M | 65.62M | 16.27M | -4.6M | 19.72M | -19.8M | -7.75M | 11.29M | -30.12M | -86.62M | -118.4M | 184.93M | -86.82M |
Free Cash Flow | -1.61M | -30.01M | -22.16M | -31.62M | -12.24M | -33.29M | -17.93M | -24.12M | -5.17M | -18.12M | -24.17M | -31.31M | -19.36M | -33.71M | -30.62M | -31.33M | -22.72M | -26.77M | -25.78M | -18.36M | -18.75M | -25.36M |
Adj. Free Cash Flow | -4.65M | -32.68M | -26.16M | -36.21M | -17.23M | -38.79M | -26.16M | -32.95M | -11.55M | -24.33M | -30.53M | -39.51M | -25.78M | -39.97M | -37.54M | -37.34M | -30.87M | -35.71M | -32.13M | -24.44M | -23.98M | -29.2M |
Maintenance CapEx | -37K | -64K | n/a | -411K | -185K | n/a | 8K | 26K | n/a | n/a | n/a | n/a | -362K | -589K | -1.49M | -3.31M | n/a | n/a | n/a | n/a | -662.72K | n/a |
Growth CapEx | n/a | n/a | -11K | n/a | n/a | n/a | -4K | -13K | -197K | n/a | -157K | -600K | n/a | n/a | n/a | n/a | -529K | -172K | -109K | n/a | -84.28K | -421K |
Owner Earnings | -1.61M | -30.01M | -22.15M | -31.62M | -12.24M | -33.29M | -17.92M | -24.11M | -4.97M | -18.12M | -24.01M | -30.71M | -19.36M | -33.71M | -30.62M | -31.33M | -22.2M | -26.6M | -25.67M | -18.36M | -18.66M | -24.93M |
Add to Watchlist
Select watchlists to add or remove CCCC